Shopping Cart
- Remove All
![TargetMol](https://www.targetmol.com/storage/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $67 | 7-10 days | |
25 mg | $297 | 7-10 days | |
1 mL x 10 mM (in DMSO) | $72 | 7-10 days |
Description | Asimadoline (EMD-61753) is a proprietary small molecule therapeutic, originally discovered by Merck KGaA of Darmstadt, Germany. Asimadoline was originally developed to treat peripheral pain such as arthritis. Asimadoline is an orally administered agent that acts as a kappa opioid receptor agonist. It has shown encouraging clinical efficacy for the treatment of IBS in a barostat study in IBS patients and has the potential for treating other gastrointestinal diseases. |
Targets&IC50 | κ opioid (Guinea pig):5.6 nM, κ opioid (human recombinant):1.2nM |
Alias | EMD-61753 |
Molecular Weight | 414.54 |
Formula | C27H30N2O2 |
Cas No. | 153205-46-0 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: 103.3 mg/mL |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.